Evidence map›Paper›PMID 19940265›Full record

ArticleCirculation research2010

Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice.

Ying Yu, Jane Stubbe, Salam Ibrahim, Wen-liang Song, Emer M Smyth, Emer M Symth, Colin D Funk, Garret A FitzGerald

Erratum issuedAbstract read
In one paragraph

Article in Circulation research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Prostanoids in Cardiac and Vascular Remodeling.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. NaHypertension (Dallas, Tex. : 1979) · 2022
    Article
  7. Article
  8. Differential compensation of two cyclooxygenases in renal homeostasis is independent of prostaglandin-synthetic capacity under basal conditions.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  9. Article
  10. Flipping the cyclooxygenase (Journal of lipid research · 2018
    Article
  11. Clinical Pharmacology and Cardiovascular Safety of Naproxen.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2017
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. An eicosanoid-centric view of atherothrombotic risk factors.Cellular and molecular life sciences : CMLS · 2012
    Review
  18. Article
  19. Article
  20. Extracellular cAMP-adenosine pathways in the mouse kidney.American journal of physiology. Renal physiology · 2011
    Article
4 · The record

Corrections and comments

  • Erratum issued
    Symth, Emer M [corrected to Smyth, Emer M]
5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ying YuInstitute for Translational Medicine and Therapeutics, University of Pennsylvania, 153 Johnson Pavilion, Philadelphia, PA 19104, USA.
Jane Stubbe
Salam Ibrahim
Wen-liang Song
Emer M Smyth
Emer M Symth
Colin D Funk
Garret A FitzGerald
Queen's University · CA

Funding

STUDIES OF PLATELET ADHERENCE TO OSTEOPONTINP01HL062250 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 1999 to 2013
$28.4M
Regulation of Vascular Eicosanoid ReceptorsR01HL066233 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SMYTH, EMER MARIA · 2002 to 2011
$2.9M
CIHR MOP-79459NHLBI NIH HHS HL066233NHLBI NIH HHS HL62250NHLBI NIH HHS P01 HL062250NHLBI NIH HHS R01 HL066233
6 · The paper itself

Abstract

rationaleCyclooxygenase (COX)-derived prostanoids (PGs) are involved in blood pressure homeostasis. Both traditional nonsteroidal antiinflammatory drugs (NSAIDs) that inhibit COX-1 and COX-2 and NSAIDs designed to be selective for inhibition of COX-2 cause sodium retention and elevate blood pressure.

objectiveTo elucidate the role of COX-2 in blood pressure homeostasis using COX-1>COX-2 mice, in which the COX-1 expression is controlled by COX-2 regulatory elements. METHODS AND

resultsCOX-1>COX-2 mice developed systolic hypertension relative to wild types (WTs) on a high-salt diet (HSD); this was attenuated by a PGI(2) receptor agonist. HSD increased expression of COX-2 in WT mice and of COX-1 in COX-1>COX-2 mice in the inner renal medulla. The HSD augmented in all strains urinary prostanoid metabolite excretion, with the exception of the major PGI(2) metabolite that was suppressed on regular chow and unaltered by the HSD in both mutants. Furthermore, inner renal medullary expression of the receptor for PGI(2), but not for other prostanoids, was depressed by HSD in WT and even more so in both mutant strains. Increasing osmolarity augmented expression of COX-2 in WT renal medullary interstitial cells and again the increase in formation of PGI(2) observed in WTs was suppressed in cells derived from both mutants. Intramedullary infusion of the PGI(2) receptor agonist increased urine volume and sodium excretion in mice.

conclusionsThese studies suggest that dysregulated expression of the COX-2 dependent, PGI(2) biosynthesis/response pathway in the renal inner renal medulla undermines the homeostatic response to a HSD. Inhibition of this pathway may contribute directly to the hypertensive response to NSAIDs.

Indexed as

AnimalsBlood PressureBlotting, WesternCells, CulturedCyclooxygenase 2EpoprostenolFemaleHomeostasisHypertensionKidney MedullaMaleMiceMice, Inbred C57BLMice, Inbred StrainsMice, KnockoutNatriuresiscicaprostCyclooxygenase 2EpoprostenolReceptors, ProstaglandinReninSodium Chloride, Dietary

Identifiers

PMID19940265
PMCPMC2818801
OpenAlexW2152625019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.